ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Liang Liu
Matched on ORCID iD 0000-0001-8630-7430; OpenAlex author ID A5100322344. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 33
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper
Papers 6
- The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape. Co-author DOI 10.1002/advs.202417724↗
- Identification of methylation driver genes for predicting the prognosis of pancreatic cancer patients based on whole-genome DNA methylation sequencing technolo… Last author DOI 10.1016/j.heliyon.2024.e29914↗
- Construction of S100 family members prognosis prediction model and analysis of immune microenvironment landscape at single-cell level in pancreatic adenocarcin… Last author DOI 10.1097/js9.0000000000001293↗
- Tumor Microenvironment Responsive CD8+ T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Based Synergistic Therapy for Pancreatic Ca… Co-author DOI 10.1002/advs.202302498↗
- IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway. Co-author DOI 10.1016/j.canlet.2020.12.008↗
- A Peptide-Based Neoantigen Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment Co-author DOI 10.21203/rs.3.rs-130888/v1↗
Closest collaborators
The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Wenquan Wang · 3 shared papers, 2023–2024 · strength 0.57
- Paper Identification of methylation driver genes for predicting the prognosis of pancreatic cancer patients based on whole-ge… DOI 10.1016/j.heliyon.2024.e29914↗
- Paper Construction of S100 family members prognosis prediction model and analysis of immune microenvironment landscape at sin… DOI 10.1097/js9.0000000000001293↗
- Paper Tumor Microenvironment Responsive CD8+ T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Bas… DOI 10.1002/advs.202302498↗
- Huaxiang Xu · 3 shared papers, 2023–2025 · strength 0.55
- Paper Construction of S100 family members prognosis prediction model and analysis of immune microenvironment landscape at sin… DOI 10.1097/js9.0000000000001293↗
- Paper The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape. DOI 10.1002/advs.202417724↗
- Paper Tumor Microenvironment Responsive CD8+ T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Bas… DOI 10.1002/advs.202302498↗
- Chenye Shi · 2 shared papers, 2023–2025 · strength 0.35
- Paper The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape. DOI 10.1002/advs.202417724↗
- Paper Tumor Microenvironment Responsive CD8+ T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Bas… DOI 10.1002/advs.202302498↗
- Ning Pu · 2 shared papers, 2023–2025 · strength 0.35
- Paper The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape. DOI 10.1002/advs.202417724↗
- Paper Tumor Microenvironment Responsive CD8+ T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Bas… DOI 10.1002/advs.202302498↗
- Hanlin Yin · 2 shared papers, 2023–2025 · strength 0.35
- Paper The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape. DOI 10.1002/advs.202417724↗
- Paper Tumor Microenvironment Responsive CD8+ T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Bas… DOI 10.1002/advs.202302498↗
- Qiangda Chen · 2 shared papers, 2023–2025 · strength 0.35
- Paper The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape. DOI 10.1002/advs.202417724↗
- Paper Tumor Microenvironment Responsive CD8+ T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Bas… DOI 10.1002/advs.202302498↗
- Wenhui Lou · 2 shared papers, 2023–2025 · strength 0.35
- Paper The Crosstalk with CXCL10-Rich Tumor-Associated Mast Cells Fuels Pancreatic Cancer Progression and Immune Escape. DOI 10.1002/advs.202417724↗
- Paper Tumor Microenvironment Responsive CD8+ T Cells and Myeloid-Derived Suppressor Cells to Trigger CD73 Inhibitor AB680-Bas… DOI 10.1002/advs.202302498↗
- Wenhui Lou · 1 shared paper, 2024 · strength 0.21
- Mengmeng Liu · 1 shared paper, 2024 · strength 0.21
- Chao Song · 1 shared paper, 2024 · strength 0.21
- Jianang Li · 1 shared paper, 2024 · strength 0.20
- Zijin Xu · 1 shared paper, 2024 · strength 0.20
- Yuquan Guo · 1 shared paper, 2024 · strength 0.20
- Sami Shoucair · 1 shared paper, 2025 · strength 0.19
- Shanshan Gao · 1 shared paper, 2025 · strength 0.19
- Lei Zhang · 1 shared paper, 2025 · strength 0.19
- Joseph R. Habib · 1 shared paper, 2025 · strength 0.19
- Taochen He · 1 shared paper, 2025 · strength 0.19
- Michael Goggins · 1 shared paper, 2025 · strength 0.19
- Yun Jin · 1 shared paper, 2025 · strength 0.19
- Lei Zhang · 1 shared paper, 2023 · strength 0.16
- Jun Yu · 1 shared paper, 2023 · strength 0.16
- Wenchuan Wu · 1 shared paper, 2023 · strength 0.16
- Longhao Sun · 1 shared paper, 2021 · strength 0.12
- Huamin Wang · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.